Beryl Drugs
BERYLDRUGS · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 25, 2007

Stock Price vs Company Growth
1d
3.5%
1w
2.3%
1m
3.2%
3m
7.7%
6m
4.1%
1y
4.5%
5y
20.4%
10y
4.1%
all
18.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 23.6 3.5%
19
26.2
Company Overview

Sales
19.3 Cr
Growth: -12.1%
Profit after Tax
0.42 Cr
Growth: 3153.8%
Micro Cap
11.9 Cr
P/E: 28.0x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 19.3
Growth -12.1%
EBITDA 12.6%
P/S 0.6x
Dividend 0.0%
P/E 28.0x
Book Value ₹ 18.4
PEG Ratio -2.0x
ROE 4.7%
P/B 1.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Beryl Drugs incorporated in 1993 is into manufacturing and marketing of branded, generic pharmaceutical formulations. The company is one of leading manufacturer of I.V.fluids and small volume injectables.Beryl has emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. The manufacturing facilities of the company are in compliance with WHO GMP specifications.
Investors (1)